Beier J, Watz H, Scholz V, et al. The efficacy of the combination indacaterol/glycopyrronium/mometasone furoate is independent of time of dosing in patients with asthma. Am J Resp Crit Care Med. 2019;199:A1277.
Voordeel van pembrolizumab vs. chemotherapie ook bij lage PD-L1-expressie
mei 2019